| • |
TICEBA is a company founded and managed by physicians.
Its aim is to offer its clients the exclusive possibility to set up and maintain a personal stock of
their own stem cells with the purpose of regenerating and preserving their bodily functions.
|
| • |
The removal of the
skin cells and the extraction of stem
cells from them should be performed as early as possible in life, as the quality of the cells naturally decreases with age.
This means: The earlier the better, but better late than never.
|
| • |
TICEBA is the only company worldwide that
is able to perform this service based on an exclusive license granted by the Brigham And Women’s Hospital,
a teaching hospital for Harvard Medical School in Boston, USA.
|
| • |
With the technology developed in Harvard - one of the globally
leading institutions in the field of medical research - we may determine the concentration of the particularly
important and versatile ABCB5-positive stem celly or isolate them, if required.
|
| • |
Only after the exact determination of their number it is guaranteed that the extracted
stem cells do in fact meet criteria that are crucial for a possible later use in regenerative medicine.
|
| • |
Furthermore, at TICEBA,
we take care of everything personally: As we have our own laboratory for cell
biology and our own cryo equipment, the risky transport of your cells is avoided and the
patented process is performed on our premises from beginning to end.
|
|
Do not settle for less when your aim is to provide for your medical care later in life!
|
|
|
 |
|
|
| |
Notice with regard to the
manufacturing license:
TICEBA possesses the required authorization by the competent authority for the manufacturing of tissue as source material of human origin for the manufacturing of pharmaceuticals in
accordance with § 20 b and § 20 c of the German Medicines Act: Authorization for the treatment or processing, preservation, storage of tissue or tissue preparations. |
|
|
|
TICEBA is full member of the following associations: |
|
|
 |
|
European Association of Pharma Biotechnology (EAPB) |
|
|
 |
|
Deutsche Gesellschaft für Regenerative Medizin (GRM) |
|
